MILWAUKEE – The Society for Clinical Data Management announced that is has recently certified its 500th Certified Clinical Data Manager (CCDM).
The CCDM credential is an elite mark of excellence in and commitment to clinical data management. Approximately 160 CCDMs were certified in 2009, nearly 40% of whom live outside North America.
“The CCDM designation is recognized globally as a standard for quality data management staff,” said 2010 SCDM Chair Ralph J. Russo, CCDM. “It provides the clinical research industry with a measure of expertise.”
Since its inception in 2005, the Certified Clinical Data Manager program has enhanced the quality and professionalism of CDMs worldwide. To earn the CCDM credential, candidates must first meet minimum standards of education and experience, then pass a challenging exam testing knowledge of best practices in all areas of clinical data management. Once obtained, certification must be renewed every three years by completing education activities or retaking the exam.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.